• Blog

    JSR Set to Offer Pre-Clinical Trial Services Using Cancer Organoids in Japan

    admin Posted on

    JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived……

    Please subscribe to read the full story.

    Author

    You Might Also Like

    Recent Posts